This site is intended for US residents only.

This site is intended for US residents only.

IPSEN CARES® offers financial assistance for eligible* patients being treated with Iqirvo® (elafibranor).

Copay Assistance

Iqirvo Copay Assistance Program

If you have been prescribed Iqirvo and you have commercial (private) insurance, you may be eligible* to receive copay assistance and pay as little as $0 per prescription for Iqirvo.

YOU MAY BE ELIGIBLE* IF YOU…

  • Have commercial (private) health insurance that covers Iqirvo
  • Have no primary or secondary insurance coverage under any state or federal healthcare program (like Medicare or Medicaid)
  • Are a resident of the US
  • Have a valid prescription for Iqirvo

Only looking for copay support?

Patient Assistance

Iqirvo Patient Assistance Program

This program is for patients who are experiencing financial hardship and who meet certain financial eligibility requirements.

YOU MAY BE ABLE TO RECEIVE FREE MEDICATION THROUGH OUR PATIENT ASSISTANCE PROGRAM IF YOU…

  • Are enrolled in IPSEN CARES
  • Are uninsured or if your insurance does not cover Iqirvo
  • Are a resident of the US
  • Have a valid prescription for on-label use of Iqirvo as supported by information provided in the program application
  • Meet program financial eligibility requirements

You must be enrolled in IPSEN CARES to be approved for the Patient Assistance Program. Please speak with your doctor if you are not enrolled.

Eligibility does not guarantee approval for participation in the Patient Assistance Program. Please talk with your doctor about enrolling in IPSEN CARES.

IPSEN CARES is a registered trademark of Ipsen Biopharm Limited.

©2025 Ipsen Biopharmaceuticals, Inc. All rights reserved.
[Month] 2025 MPSC-US-000292 V1.0

DYSPORT is a registered trademark of Ipsen S.A.

All other trademarks and registered trademarks are the property
of their respective owners.

DYSPORT is a registered trademark of Ipsen Biopharm Limited.

IPSEN CARES is a registered trademark of Ipsen S.A.

All other trademarks and registered trademarks are the property of their respective owners.

©2025 Ipsen Biopharmaceuticals, Inc. All rights reserved. August 2025 MPSC-US-000292